Bicara Therapeutics (BCAX) Interest & Investment Income (2023 - 2026)
Bicara Therapeutics (BCAX) reported Interest & Investment Income of $4.1 million for Q1 2026, down 18.57% on a YoY basis from $5.0 million in Q1 2025, and up 7.76% quarter-over-quarter from $3.8 million in Q4 2025.
Bicara Therapeutics (BCAX) Interest & Investment Income (2023 - 2026) Analysis & Trends
Bicara Therapeutics has reported Interest & Investment Income for 4 years, with the latest figure at $4.1 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 18.57% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at $16.9 million (up 1.27% YoY), and the FY2025 full-year result was $17.9 million, up 22.56% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $4.1 million, up from $3.8 million in the prior quarter.
- The five-year high for Interest & Investment Income was $5.9 million in Q4 2024, with the low at $13000.0 in Q3 2023.
- Historically, Interest & Investment Income has averaged $3.4 million across 4 years, with a median of $3.8 million in 2025.
- Annual changes were most pronounced in 2024 — Interest & Investment Income surged 24107.69% — and 2025, when it tumbled 35.41%.
- Bicara Therapeutics' Interest & Investment Income stood at $1.3 million in 2023, then soared by 350.88% to $5.9 million in 2024, then plunged by 35.41% to $3.8 million in 2025, then climbed by 7.76% to $4.1 million in 2026.
- The last three Interest & Investment Income figures came in at $4.1 million (Q1 2026), $3.8 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -14.79 Mn |
| 10 | Bicara Therapeutics | 1.31 Bn | 1.31 Bn | - | 4.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.08 Mn |
| Dec 31, 2025 | 3.79 Mn |
| Sep 30, 2025 | 4.39 Mn |
| Jun 30, 2025 | 4.68 Mn |
| Mar 31, 2025 | 5.01 Mn |
| Dec 31, 2024 | 5.87 Mn |
| Sep 30, 2024 | 3.15 Mn |
| Jun 30, 2024 | 2.70 Mn |
| Mar 31, 2024 | 2.87 Mn |
| Dec 31, 2023 | 1.30 Mn |
| Sep 30, 2023 | 13,000.00 |